32 results
6-K
EX-99.1
SNY
Sanofi
25 Apr 24
Sales growth of 6.7% at CER and business EPS(1) of €1.78
10:49am
the 1st adult patient was dosed with this compound)
Planet Care
Q1 2024
Q4 2023
Climate change - Carbon footprint
(CO2 emissions)
55% reduction
6-K
EX-99.1
SNY
Sanofi
1 Feb 24
Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
9:45am
with a dedicated Health Day with 143 countries signing a declaration on climate and health. Sanofi, with a delegation led by CEO Paul Hudson, held discussions … with health ministers, healthcare actors and NGOs willing to engage in low-carbon and climate resilient healthcare systems. Sanofi showcased its commitments
6-K
EX-99.5
SNY
Sanofi
20 Dec 23
Current report (foreign)
10:39am
or changes in climate – could put new populations at risk of T.b. rhodesiense sleeping sickness. In some cases, tourists visiting game reserves have been … philanthropic organization.
Dr Ibrahima Socé Fall
Director of Neglected Tropical Diseases, World Health Organization
“The impact of climate change extends
6-K
EX-99.1
SNY
Sanofi
27 Oct 23
Specialty Care growth, strong launch uptake of Beyfortus® and ALTUVIIIO® drive solid Q3 results
12:39pm
preparation for clinical study
2 external collaboration
contracts with the pediatric ITCC consortium established
Planet Care
Climate change - Carbon
6-K
EX-99.1
SNY
Sanofi
27 Sep 23
Current report (foreign)
6:06am
Exhibit 99.1
Press Release
Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change
Paris … by climate turbulence and by unmet medical needs. These critical initiatives come as the global healthcare company confirms its commitment
6-K
9qjd57bmp0su6r
27 Sep 23
Current report (foreign)
6:06am
6-K
EX-99.2
omn0ak6
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
6-K
EX-99.1
dh9pab y0jkj0s
27 Apr 23
Strong Q1 growth driven by Specialty Care, Vaccines and CHC
11:39am
6-K
EX-99.1
rv63xvimoc6cut zll
28 Oct 22
Continued strong growth in Q3 with key regulatory milestones achieved
11:16am
6-K
EX-99.1
83upp9r n4yyqe2i3
28 Jul 22
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
10:12am
6-K
EX-99.2
mqkoih8a042cwnq2v
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
6-K
EX-99.1
8wgoa9mvwr8l
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
6-K
EX-99.1
ecvvmicpya5ldnu3
8 Jul 22
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
11:01am
6-K
EX-99.2
vaflu5uvs 5z
9 May 22
Approval of the financial statements for the fiscal year 2021
2:29pm
6-K
EX-99.1
gyzoky9oitx9l
29 Apr 22
Current report (foreign)
12:38pm
6-K
EX-99.1
8xtpnkzdc2l
4 Apr 22
Distribution of Shares of Euroapi
11:21am
6-K
EX-99.1
xlxnt3m7
28 Oct 21
Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC
11:19am
6-K
EX-99.3
a0e32xiuza094y
8 Jun 21
Sanofi launches its new global employee share ownership plan
1:31pm
6-K
EX-99.4
rdidj89mnp01lgpx6iew
13 Apr 21
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
2:56pm